Edition:
United States

Citius Pharmaceuticals Inc (CTXR.OQ)

CTXR.OQ on NASDAQ Stock Exchange Capital Market

4.62USD
12:06pm EST
Change (% chg)

$-0.08 (-1.70%)
Prev Close
$4.70
Open
$4.72
Day's High
$4.74
Day's Low
$4.58
Volume
5,630
Avg. Vol
21,685
52-wk High
$5.46
52-wk Low
$0.34

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.00 -0.489
Mar '17 0.00 -0.549
Dec 0.00 -0.444
FY 2016 Sep '16 0.00 -0.530
Jun '16 0.00 -0.746
Mar '16 0.00 -0.350
Dec 0.00 -0.532
FY 2015 Sep '15 0.00 -0.402
Jun '15 0.00 -0.383
Mar '15 0.00 -0.166
Dec 0.00 -0.411
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.20 35.91
P/E High - Last 5 Yrs. -- 40.75 45.35
P/E Low - Last 5 Yrs. -- 23.60 24.23
Beta -- 0.92 0.91
Price to Sales (TTM) -- 3.92 5.95
Price to Book (MRQ) 2.05 4.85 5.68
Price to Tangible Book (MRQ) -- 5.73 7.29
Price to Cash Flow (TTM) -- 23.05 24.49
% Owned Institutions 0.42 0.87 1.41

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.49
Dividend Yield - 5 Year Avg -- 2.17 2.05
Dividend 5 Year Growth Rate -- 4.29 5.25
Payout Ratio(TTM) -- 47.47 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 6.31 6.79
Sales (TTM) vs TTM 1 Yr. Ago -- 5.15 5.62
Sales - 5 Yr. Growth Rate -- 9.99 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago 34.47 7.11 7.85
EPS (TTM) vs TTM 1 Yr. Ago 0.90 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.94
Capital Spending - 5 Yr. Growth Rate -- 15.15 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.49 2.55
Current Ratio (MRQ) 0.06 3.50 3.56
LT Debt to Equity (MRQ) 0.00 11.01 13.38
Total Debt to Equity (MRQ) 46.72 17.15 19.38
Interest Coverage (TTM) -3.13 49.64 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.26 54.91
Gross Margin - 5 Yr. Avg. -- 52.35 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.50 15.63
Operating Margin (TTM) -- 14.76 6.56
Operating Margin - 5 Yr. Avg. -- 14.33 11.00
Pre-Tax Margin (TTM) -- 15.21 7.41
Pre-Tax Margin - 5 Yr. Avg. -- 14.64 11.41
Net Profit Margin (TTM) -- 11.39 3.64
Net Profit Margin - 5 Yr. Avg. -- 10.98 7.70
Effective Tax Rate (TTM) -- 24.38 24.28
Effective Tax Rate - 5 Yr. Avg. -- 23.46 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 945,342,213 851,801,741
Net Income/Employee (TTM) -- 110,573,246 99,542,701
Receivable Turnover (TTM) -- 5.90 6.13
Inventory Turnover (TTM) -- 2.73 3.56
Asset Turnover (TTM) 0.00 0.99 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -44.55 11.86 11.31
Return on Assets - 5 Yr. Avg. -- 12.86 12.28
Return on Investment (TTM) -66.76 15.06 14.43
Return on Investment - 5 Yr. Avg. -- 16.81 16.07
Return on Equity (TTM) -66.76 16.55 16.01
Return on Equity - 5 Yr. Avg. -- 17.82 17.27
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -67.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Citius Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.42%
# of Holders: 5
Total Shares Held: 35,467
3 Mo. Net Change: 35,467
# New Positions: 5
# Closed Positions: 0
# Increased Positions: 5
# Reduced Positions: 0
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.